Lymphoma-associated antigen (LAA): isolation, characterization and clinical evaluation

Area of Science:

• Immunology
• Oncology
• Biochemistry

Background:

• Lymphoma-associated antigen (LAA) is a potential biomarker for lymphoid malignancies.
• Accurate detection methods are crucial for diagnosing and monitoring lymphoma.

Purpose of the Study:

• To isolate and characterize LAA from lymphoma tissues.
• To develop and validate an immunochemical assay for detecting LAA in patient samples.

Main Methods:

• Isolation and purification of LAA using chromatography techniques.
• Characterization of LAA's physicochemical properties (molecular weight, electrophoretic mobility, pI).
• Development of a radioimmunoassay (RIA) using purified LAA and specific antiserum.

Main Results:

• LAA was isolated and characterized with a molecular weight of approximately 29-43 K daltons.
• Immunochemical methods confirmed LAA presence in lymphoma patients' sera and body fluids, but not in healthy individuals or other cancer patients.
• The developed RIA demonstrated high sensitivity (22 ng/ml) and detected elevated serum LAA levels (187-1500 ng/ml) in lymphoma patients.
• Serum LAA levels correlated positively with disease progression, as confirmed by serial RIA determinations.

Conclusions:

• LAA is a specific marker for lymphomas.
• The developed RIA is a sensitive and specific tool for detecting LAA.
• Serum LAA levels can serve as a valuable indicator for monitoring lymphoma activity and patient prognosis.